Personal information

Verified email addresses

Verified email domains

CYTOGENETICS, HEMATOLOGY
Spain

Biography

Cytogenetics and molecular genetics in cancer hematology
Institut Josep Carreras

Dr. Francesc Solé is one of the world's leading authorities in Cytogenetics in Myelodysplastic Syndromes (MDS or MDS in English). He was involved in the recent IPSS-R and IPSS-M scoring systems at MDS. Dr. Solé is a reviewer for the following journals: American Journal of Hematology, Blood, British Journal of Haematology, Cancers, Genes Chromosomes and Cancer, Haematologica, Leukemia, Leukemia Research, and Leukemia and Lymphoma. He is an associate professor at the Pompeu Fabra University (Barcelona), the University of Barcelona (UB) and the Autonomous University of Barcelona (Bellaterra). From 1996 to 2008 he was coordinator of the Spanish Working Group on Cytogenetics in Hematology (GCECGH) of the SEHH (Spanish Society of Hematology and Hemotherapy). From 2004 to 2012 he was a member of the Eurogenest Hematology Quality Control Steering Committee. Since its creation, he is a member of the Spanish Group of Myelodysplastic Syndromes (GESMD) and of the world MDS group, IWG-PM, and since 2012 he is a member of the ELN. Currently, he is the Scientific Coordinator of the Josep Carreras Leukemia Research Institute-ICO-GTiP Campus (Badalona), Coordinator of the Biological Sample Bank Unit for patients with haematological cancer, Cytogenetics Unit and Microarray Unit and Head of Group of the MDS Group. He is the author of more than 300 peer-reviewed publications and serves on multiple national committees and scientific advisory boards for numerous for-profit and non-profit organizations.

Activities

Employment (1)

Institut de Recerca Contra la Leucemia Josep Carreras: Barcelona, ES

2012 to present | Principal investigator (MDS Group)
Employment
Source: Self-asserted source
Sole F; Francesc Sole

Professional activities (6)

ELN: Europa, ES

Membership
Source: Self-asserted source
Sole F; Francesc Sole

IWG-PM: USA, US

2012 to present | Steeting committee
Membership
Source: Self-asserted source
Sole F; Francesc Sole

GESMD: Madrid, ES

1988 to present | Miembro
Membership
Source: Self-asserted source
Sole F; Francesc Sole

GCECGH: Batcelona, ES

1988 to present | Miembro
Membership
Source: Self-asserted source
Sole F; Francesc Sole

GESMD: Madrid, ES

2012 to 2018 | Vice presidente
Invited position
Source: Self-asserted source
Sole F; Francesc Sole

GCECGH: Barcelona, ES

1990 to 2012 | Presidente
Invited position
Source: Self-asserted source
Sole F; Francesc Sole

Funding (5)

Caracterización del paisaje germinal y somático de las neoplasias mieloides asociadas a tratamiento (TRMN)”

2024-01 to 2026-12 | Grant
Ministerio de Economía y Competitividad (Madrid, ES)
Source: Self-asserted source
Sole F; Francesc Sole

SGR

2022 to 2024 | Grant
Generalitat de Catalunya (Barcelona, ES)
Source: Self-asserted source
Sole F; Francesc Sole

Proyecto de Investigación FIS Instituto de Salud Carlos III. Ministerio de Ministerio de Economía y Competitividad. “Caracterización genética de las neoplasias mieloides asociadas a tratamiento (TRMN)”.

2021-01 to 2023-12 | Grant
ISCIII (Madrid, ES)
Source: Self-asserted source
Sole F; Francesc Sole

Proyecto de Investigación TRANSCAN “An Integrated European Platform to conduct translational studies in Myelodysplastic Syndromes base ont the EuroBloodNet Infraestructure”. PI. Francesc SOLÉ, Equipo Investigador: Mar Mallo, Laura Palomo, Pamela Acha, Francisco Fuster, Paula Gomez, Nuri de Haro, Lurdes Zamora, Blanca Xicoy. Coordinador Europeo: Matteo Dalla Porta (Italia). Colaboradores: Pierre Fenaux (Francia), Uwe Platzbecker (Alemania) y Francesc Solé (España). Importe nodo España: 245.500 euros. ISCIII 150.000 € + AECC 95.500 €. Periodo 2019-2022. Ref. AC 18/000002.

2018 to 2022 | Grant
TRANSCAN (Europa, ES)
Source: Self-asserted source
Sole F; Francesc Sole

Proyecto de Investigación FIS Instituto de Salud Carlos III. Ministerio de Ministerio de Economía y Competitividad. “Aplicación de la secuenciación masiva (NGS) en el diagnóstico de los síndromes mielodisplásicos/neoplasias mieloproliferativas”.

2018 to 2020 | Grant
ISCIII (Madrid, ES)
Source: Self-asserted source
Sole F; Francesc Sole

Peer review (10 reviews for 7 publications/grants)

Review activity for British journal of haematology. (2)
Review activity for Cancers. (2)
Review activity for Current research in translational medicine. (1)
Review activity for Cytometry. (1)
Review activity for International journal of cancer. (2)
Review activity for npj precision oncology. (1)
Review activity for The lancet. (1)